KRONTHALER; Ulrich

Patent Applications and Registrations

Patent applications and USPTO patent grants for KRONTHALER; Ulrich.The latest application filed is for "glycoprotein with reduced acetylation rate of sialic acid residues".

Company Profile

2.9.14

KRONTHALER; Ulrich - Holzkirchen DE
KRONTHALER; Ulrich - Deisenhofen DE
Kronthaler; Ulrich - Marburg N/A DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Glycoprotein With Reduced Acetylation Rate Of Sialic Acid Residues App 20220119471 - KRONTHALER; Ulrich ; et al.	2022-04-21
Glycoprotein With Reduced Acetylation Rate Of Sialic Acid Residues App 20190177385 - KRONTHALER; Ulrich ; et al.	2019-06-13
MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE App 20170080061 - WEIMER; Thomas ; et al.	2017-03-23
Methods And Formulations Which Allow The Modulation Of Immune Responses Related To The Administration Of A Biopharmaceutical Drug App 20160151484 - KRONTHALER; Ulrich ; et al.	2016-06-02
Factor VIII, von Willebrand factor or complexes thereof with prolonged in vivo half-life Grant 9,290,561 - Weimer , et al. March 22, 2	2016-03-22
Use of VWF stabilized FVIII preparations and of VWF preparations without FVIII for extravascular administration in the therapy and prophylactic treatment of bleeding disorders Grant 9,107,902 - Kronthaler August 18, 2	2015-08-18
MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE App 20140356346 - WEIMER; Thomas ; et al.	2014-12-04
Modified coagulation factor VIIa with extended half-life Grant 8,765,915 - Weimer , et al. July 1, 2	2014-07-01
Factor Viii, Von Willebrand Factor Or Complexes Thereof With Prolonged In Vivo Half-life App 20140072561 - Weimer; Thomas ; et al.	2014-03-13
Factor VIII, von willebrand factor or complexes thereof with prolonged in vivo half-life Grant 8,575,104 - Weimer , et al. November 5, 2	2013-11-05
Therapeutic application of Kazal-type serine protease inhibitors Grant 8,283,319 - Schulte , et al. October 9, 2	2012-10-09
Albumin Fused Coagulation Factors For Non-intravenous Administration In The Therapy And Prophylactic Treatment Of Bleeding Disorders App 20120148557 - Kronthaler; Ulrich	2012-06-14
Method For The Prevention And Treatment Of Cancer By Inhibition Of Gpvi App 20120039901 - Kronthaler; Ulrich ; et al.	2012-02-16
Factor Viii, Von Willebrand Factor Or Complexes Thereof With Prolonged In Vivo Half-life App 20110183907 - Weimer; Thomas ; et al.	2011-07-28
Method For The Prevention And Treatment Of Cancer By Inhibition Of Gpvi App 20110044993 - Kronthaler; Ulrich ; et al.	2011-02-24
Use Of Vwf Stabilized Fviii Preparations And Of Vwf Preparations Without Fviii For Extravascular Administration In The Therapy And Prophylactic Treatment Of Bleeding Disorders App 20100286047 - Kronthaler; Ulrich	2010-11-11
Therapeutic Application Of Kazal-type Serine Protease Inhibitors App 20100279923 - Schulte; Stefan ; et al.	2010-11-04
Modified Coagulation Factor VIIa With Extended Half-Life App 20090298760 - Weimer; Thomas ; et al.	2009-12-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.